Benidipine
From Wikipedia, the free encyclopedia
 |
|
|
Benidipine
|
|
| Systematic (IUPAC) name | |
| O5-methyl O3-[(3R)-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
| Identifiers | |
| CAS number | ? |
| ATC code | C08 |
| PubChem | |
| Chemical data | |
| Formula | C28H31N3O6 |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Benidipine (INN), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension).
[edit] Dosing
Benidipine is dosed as 2-4 mg once daily.[1]
[edit] Availability
Benidipine is sold as Coniel® by Kyowa Hakko Kogyo.
Benidipine is only licensed for use in Japan and selected Southeast Asian countries, where it is sold as 4 mg tablets.
[edit] References
- ^ Hi-Eisai Pharmaceutical, Inc.. Coniel (benidipine) package insert (Philippines). MIMS Philippines. CMPMedica. Retrieved on 2008-03-31.
|
|||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
